Patrick McGuire - 18 Feb 2026 Form 3 Insider Report for Organogenesis Holdings Inc. (ORGO)

Role
Chief Accounting Officer
Signature
/s/ William R. Kolb, Attorney-in-Fact
Issuer symbol
ORGO
Transactions as of
18 Feb 2026
Net transactions value
$0
Form type
3
Filing time
27 Feb 2026, 16:19:23 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McGuire Patrick Chief Accounting Officer C/O ORGANOGENESIS HOLDINGS INC., 85 DAN ROAD, CANTON /s/ William R. Kolb, Attorney-in-Fact 27 Feb 2026 0002112688

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ORGO Class A Common Stock 9,521 18 Feb 2026 Direct F2
holding ORGO Class A Common Stock 16,965 18 Feb 2026 Direct F1, F3
holding ORGO Class A Common Stock 28,125 18 Feb 2026 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock.
F2 Represents shares of Class A Common Stock of Organogenesis pursuant to vested RSUs under the 2018 Equity Incentive Plan.
F3 Represents unvested RSUs which will vest in equal annual installments on December 29, 2026, December 29, 2027, and December 29, 2028.
F4 Represents unvested RSUs which will vest in equal annual installments on February 15, 2027, February 15, 2028, and February 15, 2029.

Remarks:

Exhibit 24 Power of Attorney filed herewith.